ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,933 | -4.5% | 91,100 | +8.2% | 0.00% | – |
| Q2 2023 | $193,591 | +11.5% | 84,170 | +46.9% | 0.00% | – |
| Q1 2023 | $173,619 | +51.8% | 57,300 | +16.7% | 0.00% | – |
| Q4 2022 | $114,403 | +87.5% | 49,100 | +54.4% | 0.00% | – |
| Q3 2022 | $61,000 | -7.6% | 31,800 | +31.4% | 0.00% | – |
| Q2 2022 | $66,000 | +57.1% | 24,200 | +71.6% | 0.00% | – |
| Q1 2022 | $42,000 | -23.6% | 14,100 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | -8.3% | 14,100 | 0.0% | 0.00% | – |
| Q3 2021 | $60,000 | +39.5% | 14,100 | 0.0% | 0.00% | – |
| Q2 2021 | $43,000 | -84.8% | 14,100 | -52.7% | 0.00% | – |
| Q3 2018 | $282,000 | – | 29,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |